- Home
- INFU vs OBIO Comparison
INFU vs OBIO Comparison
Compare INFU & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- OBIO
- Stock Information
- Founded
- INFU 2005
- OBIO 2017
- Country
- INFU United States
- OBIO United States
- Employees
- INFU N/A
- OBIO N/A
- Industry
- INFU Medical/Dental Instruments
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- INFU Health Care
- OBIO Health Care
- Exchange
- INFU Nasdaq
- OBIO Nasdaq
- Market Cap
- INFU 124.0M
- OBIO 118.8M
- IPO Year
- INFU N/A
- OBIO N/A
- Fundamental
- Price
- INFU $5.70
- OBIO $2.44
- Analyst Decision
- INFU Strong Buy
- OBIO Strong Buy
- Analyst Count
- INFU 1
- OBIO 4
- Target Price
- INFU $12.00
- OBIO $14.00
- AVG Volume (30 Days)
- INFU 103.0K
- OBIO 142.8K
- Earning Date
- INFU 08-11-2025
- OBIO 08-11-2025
- Dividend Yield
- INFU N/A
- OBIO N/A
- EPS Growth
- INFU 3654.89
- OBIO N/A
- EPS
- INFU 0.15
- OBIO N/A
- Revenue
- INFU $137,582,000.00
- OBIO $2,886,000.00
- Revenue This Year
- INFU $11.06
- OBIO $20.47
- Revenue Next Year
- INFU $7.86
- OBIO $11.45
- P/E Ratio
- INFU $37.97
- OBIO N/A
- Revenue Growth
- INFU 7.98
- OBIO 30.23
- 52 Week Low
- INFU $4.61
- OBIO $2.37
- 52 Week High
- INFU $9.97
- OBIO $7.62
- Technical
- Relative Strength Index (RSI)
- INFU 45.43
- OBIO 31.22
- Support Level
- INFU $5.38
- OBIO $3.05
- Resistance Level
- INFU $6.31
- OBIO $3.53
- Average True Range (ATR)
- INFU 0.20
- OBIO 0.19
- MACD
- INFU -0.01
- OBIO -0.05
- Stochastic Oscillator
- INFU 50.79
- OBIO 0.00
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.